Neuroone Medical Technologies (NMTC) Enterprise Value (2017 - 2025)
Neuroone Medical Technologies (NMTC) has disclosed Enterprise Value for 7 consecutive years, with -$3.6 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Enterprise Value fell 217.36% year-over-year to -$3.6 million, compared with a TTM value of -$3.6 million through Dec 2025, down 217.36%, and an annual FY2025 reading of -$6.6 million, down 350.01% over the prior year.
- Enterprise Value was -$3.6 million for Q4 2025 at Neuroone Medical Technologies, up from -$6.6 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$1.1 million in Q4 2024 and bottomed at -$16.2 million in Q4 2021.
- Average Enterprise Value over 5 years is -$6.4 million, with a median of -$5.9 million recorded in 2023.
- The sharpest move saw Enterprise Value soared 72.57% in 2024, then crashed 393.83% in 2025.
- Year by year, Enterprise Value stood at -$16.2 million in 2021, then skyrocketed by 52.78% to -$7.6 million in 2022, then surged by 64.92% to -$2.7 million in 2023, then soared by 57.69% to -$1.1 million in 2024, then tumbled by 217.36% to -$3.6 million in 2025.
- Business Quant data shows Enterprise Value for NMTC at -$3.6 million in Q4 2025, -$6.6 million in Q3 2025, and -$8.0 million in Q2 2025.